Increased C-reactive protein is associated with future development of diabetes mellitus in essential hypertensive patients

Heart and Vessels

Volumn 25, Issue 5, 2010, Pages 386-391

  Weng, Chiung Mei ^a   Chou, Chang Hua ^b   Huang, Yao Yi ^a   Lin, Chih Chan ^a   Liu, Yen Wen ^a   Tsai, Wei Chuan ^a  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^b TAINAN SIN LAU HOSPITAL   (Taiwan)

Author keywords

Diabetes mellitus; High sensitivity C reactive protein; Hypertension

Indexed keywords

ADIPONECTIN; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; LOW DENSITY LIPOPROTEIN; THIAZIDE DIURETIC AGENT; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DIABETES MELLITUS; DIABETOGENESIS; DISEASE ASSOCIATION; ESSENTIAL HYPERTENSION; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HAZARD RATIO; HUMAN; INFLAMMATION; MALE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

ADRENERGIC BETA-ANTAGONISTS; ADULT; ANTIHYPERTENSIVE AGENTS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; C-REACTIVE PROTEIN; CHOLESTEROL; CHOLESTEROL, LDL; DIABETES MELLITUS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; HYPERTENSION; KAPLAN-MEIER ESTIMATE; LINEAR MODELS; LOGISTIC MODELS; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TAIWAN; TIME FACTORS; TRIGLYCERIDES;

EID: 77956016267     PISSN: 09108327     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00380-009-1218-2     Document Type: Article

References (37)

1. K. Wolf-Maier R.S. Cooper J.R. Banegas S. Giampaoli H.W. Hense M. Joffres M. Kastarinen N. Poulter P. Primatesta F. Rodriguez-Artalejo 2003 Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States JAMA 289 2363 2369 10.1001/jama.289.18.2363 12746359
2. C. Pitsavos C. Chrysohoou D.B. Panagiotakos Y. Lentzas C. Stefanadis 2008 Andominal obesity and inflammation predicts hypertension among prehypertensive men and women: the ATTICA study Heart Vessels 23 96 103 10.1007/s00380-007-1018- 5 18389333
3. S.S. Holcomb 2005 Selection of antihypertensive agents in patients at risk for diabetes Curr Hypertens Rep 7 461 465 10.1007/s11906-005-0042-z 1:CAS:528:DC%2BD28XhtFaiu78%3D 16386203
4. T. Kasai K. Miyauchi K. Kajimoto N. Kubota T. Kurata H. Daida 2008 Influence of diabetes on >10-year outcomes after percutaneous coronary intervention Heart Vessels 23 149 154 10.1007/s00380-007-1021-x 18484156
5. T.W. Gress F.J. Nieto E. Shahar M.R. Wofford F.L. Brancati 2000 Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus: Atherosclerosis Risk in Communities Study N Engl J Med 342 905 912 10.1056/NEJM200003303421301 1:CAS:528:DC%2BD3cXisFWmt7o%3D 10738048
6. The Diabetes Prevention Program 1999 Design and methods for a clinical trial in the prevention of type 2 diabetes Diabetes Care 22 623 634 10.2337/diacare.22.4.623
7. A.A. Mansour M.I. Al-Jazairi 2007 Predictors of incident diabetes mellitus in Basrah, Iraq Ann Nutr Metab 51 277 280 10.1159/000105449 1:CAS:528:DC%2BD2sXpt1KhtL8%3D 17622787
8. A.J. Zillich J. Garg S. Basu G.L. Bakris B.L. Carter 2006 Thiazide diuretics, potassium, and the development of diabetes: a quantitative review Hypertension 48 219 224 10.1161/01.HYP.0000231552.10054.aa 1:CAS:528: DC%2BD28XmvFalu74%3D 16801488
9. S. Bangalore S. Parkar E. Grossman F.H. Messerli 2007 A meta-analysis of 94,492 patients with hypertension treated with beta blockers to determine the risk of new-onset diabetes mellitus Am J Cardiol 100 1254 1262 10.1016/j.amjcard.2007.05.057 1:CAS:528:DC%2BD2sXhtFCjsLfE 17920367
10. A.J. Scheen 2004 Renin-angiotensin system inhibition prevents type 2 diabetes mellitus. Part 1. A meta-analysis of randomised clinical trials Diabetes Metab 30 487 496 10.1016/S1262-3636(07)70146-5 1:CAS:528: DC%2BD2MXhtVCnt7s%3D 15671918
11. G. Mancia G. Grassi A. Zanchetti 2004 New-onset diabetes and antihypertensive drugs J Hypertens 24 3 10 10.1097/01.hjh.0000194119.42722.21
12. S.S. Bassuk N. Rifai P.M. Ridker 2004 High-sensitive C-reactive protein Curr Probl Cardiol 29 439 493 15258556
13. P.M. Ridker 2007 C-reactive protein and the prediction of cardiovascular events among those at intermediate risk J Am Coll Cardiol 49 2129 2138 10.1016/j.jacc.2007.02.052 1:CAS:528:DC%2BD2sXlvVOrsbo%3D 17531663
14. L.E. Bautista J.E. Atwood P.G. O'Malley A.J. Taylor 2004 Association between C-reactive protein and hypertension in healthy middle-aged men and women Coron Artery Dis 15 331 336 10.1097/00019501-200409000-00006 15346091
15. W.C. Tsai C.C. Lin Y.Y. Huang J.Y. Chen J.H. Chen 2007 Association of increased arterial stiffness and inflammation with proteinuria and left ventricular hypertrophy in non-diabetic hypertensive patients Blood Press 16 270 275 10.1080/08037050701464443 1:CAS:528:DC%2BD2sXhtFWqsrrL 17852088
16. A. Pfutzner T. Forst 2006 High-sensitivity C-reactive protein as cardiovascular risk marker in patients with diabetes mellitus Diabetes Technol Ther 8 28 36 10.1089/dia.2006.8.28 16472048
17. L. Lu L.J. Pu X.W. Xu Q. Zhang R.Y. Zhang J.S. Zhang J. Hu Z.K. Yang A.K. Lu F.H. Ding J. Shen Q.J. Chen S. Lou D.H. Fang W.F. Shen 2007 Association of serum levels of glycated albumin, C-reactive protein and tumor necrosis factor-alpha with the severity of coronary artery disease and renal impairment in patients with type 2 diabetes mellitus Clin Biochem 40 810 816 10.1016/j.clinbiochem.2007.03.022 1:CAS:528:DC%2BD2sXntF2rtrY%3D 17499233
18. S. Liu L. Tinker Y. Song N. Rifai D.E. Bonds N.R. Cook G. Heiss B.V. Howard G.S. Hotamisligil F.B. Hu L.H. Kuller J.E. Manson 2007 A prospective study of inflammatory cytokines and diabetes mellitus in a multiethnic cohort of postmenopausal women Arch Intern Med 167 1676 1685 10.1001/archinte.167.15.1676 1:CAS:528:DC%2BD2sXhtVSqtrvE 17698692
19. N. Kondo M. Nomura Y. Nakaya S. Ito T. Ohguro 2005 Association of inflammatory marker and highly sensitive C-reactive protein with aerobic exercise capacity, maximum oxygen uptake and insulin resistance in healthy middle-aged volunteers Circulation J 69 452 457 10.1253/circj.69.452 1:CAS:528:DC%2BD2MXjsFyqtbw%3D
20. D.J. Freeman J. Norrie M.J. Caslake A. Gaw I. Ford G.D. Lowe D.S. O'Reilly C.J. Packard N. Sattar 2002 C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study Diabetes 51 1596 1600 10.2337/diabetes.51.5.1596 1:CAS:528:DC%2BD38XjtlGmur8%3D 11978661
21. W.C. Tsai C.C. Lin J.Y. Chen Y.Y. Huang C.H. Lee W.T. Li C.M. Weng J.H. Chen 2008 Association of adiponectin with procollagen type I carboxyterminal propeptide in non-diabetic essential hypertension Blood Press 17 233 238 10.1080/08037050802308895 1:CAS:528:DC%2BD1cXht1KrtbzO 18671144
22. M. Emoto Y. Nishizawa K. Maekawa Y. Hiura H. Kanda T. Kawagishi T. Shoji Y. Okuno H. Morii 1999 Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas Diabetes Care 22 818 822 10.2337/diacare.22.5.818 1:STN:280:DyaK1M3msFSqsA%3D%3D 10332688
23. G.G. Biondi-Zoccai A. Abbate G. Liuzzo L.M. Biasucci 2003 Atherothrombosis, inflammation, and diabetes J Am Coll Cardiol 41 1071 1077 10.1016/S0735-1097(03)00088-3 1:CAS:528:DC%2BD3sXjtlKhu78%3D 12679203
24. B. Vozarova C. Weyer R.S. Lindsay R.E. Pratley C. Bogardus P.A. Tataranni 2002 High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes Diabetes 51 455 461 10.2337/diabetes.51.2.455 1:CAS:528:DC%2BD38XhtVaqu7Y%3D 11812755
25. E.S. Ford 2002 Leukocyte count, erythrocyte sedimentation rate, and diabetes incidence in a national sample of U.S. adults Am J Epidemiol 155 57 64 10.1093/aje/155.1.57 11772785
26. M. Rizzo E. Corrado G. Coppola I. Muratori A. Mezzani G. Novo S. Novo 2009 The predictive role of C-reactive protein in patients with hypertension and subclinical atherosclerosis Intern Med J 39 539 545 10.1111/j.1445-5994.2009. 01955.x 1:CAS:528:DC%2BD1MXht1WqtrjE 19323703
27. G. Schillaci M. Pirro F. Gemelli L. Pasqualini G. Vaudo S. Marchesi D. Siepi F. Bagaglia E. Mannarino 2003 Increased C-reactive protein concentrations in never-treated hypertension: the role of systolic and pulse pressure J Hypertens 21 1841 1846 10.1097/00004872-200310000-00010 1:CAS:528: DC%2BD3sXnsFSgu7g%3D 14508189
28. E.D. Michos R.S. Blumenthal 2009 Prevalence of low-density lipoprotein cholesterol with elevated high sensitivity C-reactive protein in the U.S. J Am Coll Cardiol 53 931 935 10.1016/j.jacc.2008.12.010 1:CAS:528: DC%2BD1MXjtFOjsLs%3D 19281922
29. C.J. Ge S.Z. Lu Y.D. Chen X.F. Wu S.J. Hu Y. Ji 2008 Synergistic effect of amlodipine on blood pressure, left ventricular remodeling, and C-reactive protein in hypertensive patients with primary hypercholesterolemia Heart Vessels 23 91 95 10.1007/s00380-007-1008-7 18389332
30. R. Futai T. Ito Y. Kawanishi F. Terasaki Y. Kitaura 2009 Olmesartan ameliorates myocardial function independent of blood pressure control in patients with mild-to-moderate hypertension Heart Vessels 24 294 300 10.1007/s00380-008-1119-9 19626403
31. E. Rytter B. Vessby R. Asgard C. Johansson A. Sjodin L. Abramsson-Zetterberg L. Moller S. Basu 2009 Glycemic status in relation to oxidative stress and inflammation in well-controlled type 2 diabetes subjects Br J Nutr 101 1423 1426 10.1017/S0007114508076204 1:CAS:528:DC%2BD1MXnslSls7s%3D 19459227
32. N. Kondo M. Nomura Y. Nakaya S. Ito T. Ohguro 2005 Association of inflammatory marker and highly sensitive C-reactive protein with aerobic exercise capacity, maximum oxygen uptake and insulin resistance in healthy middle-aged volunteers Circulation J 69 452 457 10.1253/circj.69.452 1:CAS:528:DC%2BD2MXjsFyqtbw%3D
33. S. Bangalore S. Parkar E. Grossman F.H. Messerli 2007 A meta-analysis of 94,492 patients with hypertension treated with beta blockers to determine the risk of new-onset diabetes mellitus Am J Cardiol 100 1254 1262 10.1016/j.amjcard.2007.05.057 1:CAS:528:DC%2BD2sXhtFCjsLfE 17920367
34. E. Ferrannini G. Buzzigoli R. Bonadonna M.A. Giorico M. Oleggini L. Graziadei R. Pedrinelli L. Brandi S. Bevilacqua 1987 Insulin resistance in essential hypertension N Engl J Med 317 350 357 10.1056/NEJM198708063170605 1:STN:280:DyaL2s3lvVWiuw%3D%3D 3299096
35. L. Lissner C. Bengtsson L. Lapidus K. Kristjansson H. Wedel 1992 Fasting insulin in relation to subsequent blood pressure changes and hypertension in women Hypertension 20 797 801 1:STN:280:DyaK3s%2FosVejsQ%3D%3D 1452295
36. L. Taittonen M. Uhari M. Nuutinen J. Turtinen T. Pokka H.K. Akerblom 1996 Insulin and blood pressure among healthy children: cardiovascular risk in young Finns Am J Hypertens 9 194 199 10.1016/0895-7061(95)00345-2 1:STN:280:DyaK283lvVShtw%3D%3D 8695016
37. Gensini GF, Gori AM, Dilaghi B, Rostagno C, Gaw A, Blanco-Colio LM, de Teresa E, Egido J, Farsang C, Leiter LA, Martineau P, Nozza A, Langer A (2009) Effect of atorvastatin on circulating hsCRP concentrations: A sub-study of the Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titration (ACTFAST) study. Int J Cardiol (Epub ahead of print)